183 results
Page 4 of 10
8-K
EX-4.3
sbspntrb c2fp5ssppq
13 Sep 22
InMed Pharmaceuticals Announces $6 Million Private Placement Priced at a Premium to Market
9:59pm
8-K
EX-4.2
g3wmc54pnx x19
13 Sep 22
InMed Pharmaceuticals Announces $6 Million Private Placement Priced at a Premium to Market
9:59pm
8-K
EX-99.1
c80dv19sjhapd038c
26 Jul 22
InMed Announces Update on Phase 2 Clinical Trial Investigating INM-755 Cannabinol Cream for Epidermolysis Bullosa
1:32pm
8-K
EX-10.1
rqk dbtir
19 Jul 22
InMed Announces Appointment of Chief Operating Officer
7:43pm
424B3
hvb3ljo2vtfhw5 ll
6 Jul 22
Prospectus supplement
2:43pm
8-K
EX-10.3
rmztym4aaxv noclxr6
3 Jun 22
Entry into a Material Definitive Agreement
9:51pm
8-K
EX-4.1
c11eph
3 Jun 22
Entry into a Material Definitive Agreement
9:51pm
8-K
EX-4.2
j6nx01x0r
3 Jun 22
Entry into a Material Definitive Agreement
9:51pm
8-K
EX-10.1
ohpl88scdpoxgt9 39qu
3 Jun 22
Entry into a Material Definitive Agreement
9:51pm
8-K
EX-10.2
28zl3lo i3wz11
3 Jun 22
Entry into a Material Definitive Agreement
9:51pm
8-K
EX-4.3
9rckzl9 o2ap0yb
3 Jun 22
Entry into a Material Definitive Agreement
9:51pm
424B5
8vc8yi139 xt
3 Jun 22
Prospectus supplement for primary offering
9:45pm
8-K
EX-99.1
gd3j06xrzkzy etp
6 May 22
Regulation FD Disclosure
2:50pm
424B3
qzezkf
25 Apr 22
Prospectus supplement
5:02pm
8-K
EX-10.1
do4dfwy q45
7 Apr 22
Entry into a Material Definitive Agreement
4:47pm
8-K
EX-5.1
flb3kpk88w5kej2um1ye
7 Apr 22
Entry into a Material Definitive Agreement
4:47pm